0001209191-21-064246.txt : 20211112 0001209191-21-064246.hdr.sgml : 20211112 20211112165528 ACCESSION NUMBER: 0001209191-21-064246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211110 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BORGESON JOHN A. CENTRAL INDEX KEY: 0001754045 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38682 FILM NUMBER: 211404534 MAIL ADDRESS: STREET 1: 1200 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kodiak Sciences Inc. CENTRAL INDEX KEY: 0001468748 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270476525 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PAGE MILL RD CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-281-0850 MAIL ADDRESS: STREET 1: 1200 PAGE MILL RD CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: Oligasis, LLC DATE OF NAME CHANGE: 20090721 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-10 0 0001468748 Kodiak Sciences Inc. KOD 0001754045 BORGESON JOHN A. 1200 PAGE MILL ROAD PALO ALTO CA 94304 0 1 0 0 See Remarks Common Stock 2021-11-10 4 S 0 672 115.1583 D 169647 D Common Stock 2021-11-10 4 S 0 204 116.2949 D 169443 D The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $115.00 to $115.95, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $116.29 to $116.625, inclusive. Senior VP and Chief Financial Officer /s/ David Peinsipp, Attorney-in-Fact for John A. Borgeson 2021-11-12